The pathological process underlying Alzheimer’s disease in individuals under thirty

Braak, Heiko, Del Tredici, Kelly·2011·Acta Neuropathologica
DOI 10.1007/s00401-010-0789-4

Cited by (813)

Items 501–600 of 813

  1. On the origin of tau seeding activity in Alzheimer’s disease
    Helmut Heinsen, Lea T. Grinberg · 2018 · Acta Neuropathologica
  2. Attention Measures of Accuracy, Variability, and Fatigue Detect Early Response to Donepezil in Alzheimer’s Disease: A Randomized, Double-blind, Placebo-Controlled Pilot Trial
    Clara Vila‐Castelar, Jenny J. Ly, Lillian R. Kaplan, Kathleen Van Dyk, Jeffrey Todd Berger, Lucy O. Macina, Jennifer Lorraine Stewart, Nancy S. Foldi · 2018 · Archives of Clinical Neuropsychology
  3. Tau and Amyloid-β Pathology in Japanese Forensic Autopsy Series Under 40 Years of Age: Prevalence and Association with APOE Genotype and Suicide Risk
    Koji Yoshida, Yukiko Hata, Shojiro Ichimata, Naoki Nishida · 2019 · Journal of Alzheimer s Disease
  4. Periphery Biomarkers for Objective Diagnosis of Cognitive Decline in Type 2 Diabetes Patients
    Yanchao Liu, Shujuan Zhang, Benrong He, Liangkai Chen, Dan Ke, Shi Zhao, Yao Zhang, Wei Wei, Zhipeng Xu, Zihui Xu et al. · 2021 · Frontiers in Cell and Developmental Biology
  5. Clustering of activated microglia occurs before the formation of dystrophic neurites in the evolution of Aβ plaques in Alzheimer’s disease.
    Patrick Jarmo Paasila, Danielle Davies, Greg Trevor Sutherland, Claire S. Goldsbury · 2020 · Free Neuropathology
  6. Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
    Rakez Kayed, Diana Laura Castillo‐Carranza, Marcos Jair Guerrero‐Munoz · 2013 · ImmunoTargets and Therapy
  7. Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer’s Disease
    Gomar, Jesus J., Conejero-Goldberg, Concepcion, Davies, Peter, Goldberg, Terry E., for the Alzheimer’s Disease Neuroimaging Initiative · 2016 · Journal of Alzheimer’s Disease
  8. The unique neuropathological vulnerability of the human brain to aging
    Isidró Ferrer · 2023 · Ageing Research Reviews
  9. Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus
    Barbara Sárkány, Csaba Dávid, Tibor Hortobágyi, Péter Gombás, Péter Somogyi, László Acsády, Tim J. Viney · 2024 · Acta Neuropathologica
  10. Genetics and Neuropathology of Neurodegenerative Dementias
    Sonja W. Scholz, Inma Cobos · 2024 · CONTINUUM Lifelong Learning in Neurology
  11. Modeling Alzheimer’s Disease: A Review of Gene-Modified and Induced Animal Models, Complex Cell Culture Models, and Computational Modeling
    Anna M. Timofeeva, Kseniya S. Aulova, Georgy A. Nevinsky · 2025 · Brain Sciences
  12. Is There Any Evidence of Monocytes Involvement in Alzheimer’s Disease? A Pilot Study on Human Postmortem Brain
    Camelia-Maria Monoranu, Tim Hartmann, Sabrina Strobel, Helmut Heinsen, Peter Riederer, Luitpold Valentin Distel, Simone Bohnert · 2021 · Journal of Alzheimer s Disease Reports
  13. Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s Disease
    Benjamín Pizarro-Galleguillos, Liesa Kunert, Norbert Brüggemann, Jannik Prasuhn · 2022 · International Journal of Molecular Sciences
  14. Association of Tooth Loss with Alzheimer’s Disease Tau Pathologies Assessed by Positron Emission Tomography
    Hideki Matsumoto, Kenji Tagai, Hironobu Endo, Kiwamu Matsuoka, Yuhei Takado, Naomi Kokubo, Hitoshi Shimada, Tetsuya Goto, Tazuko K. Goto, Makoto Higuchi · 2023 · Journal of Alzheimer s Disease
  15. Chronic traumatic encephalopathy: A paradigm in search of evidence?
    Rudy J. Castellani · 2015 · Laboratory Investigation
  16. Radioligand binding analysis of α2 adrenoceptors with [11C]yohimbine in brain in vivo: Extended Inhibition Plot correction for plasma protein binding
    Jenny-Ann Phan, Anne Marlene Landau, Steen Jakobsen, Dean Foster Wong, ALBERT H. GJEDDE · 2017 · Scientific Reports
  17. Tau Aggregation Correlates with Amyloid Deposition in Both Mild Cognitive Impairment and Alzheimer’s Disease Subjects
    Melanie Dani, Melanie Wood, Ruth Mizoguchi, Zhen Fan, Trudi L. Edginton, Rainer Hinz, Zarni Win, David James Brooks, Paul Edison · 2019 · Journal of Alzheimer s Disease
  18. Human microglial transitions at the Aβ–tau inflection point associate with divergent pathways to dementia and resilience
    Ashley Lu, Wei-Ting Chen, Maria Dalby, Diego Sáinz García, Marisa Vanheusden, Luuk E. de Vries, Veerle van Lieshout, Araks Martirosyan, Katleen Craessaerts, Sebastiaan Moonen et al. · 2026 · Nature Medicine
  19. Basal forebrain activity predicts functional degeneration in the entorhinal cortex in Alzheimer’s disease
    Marthe Mieling, Martin Göttlich, Mushfa Yousuf, Nico Bunzeck, the Alzheimer’s Disease Neuroimaging Initative · 2023 · Brain Communications
  20. The Sub-Classification of Amnestic Mild Cognitive Impairment Using MRI-Based Cortical Thickness Measures
    Pradeep Reddy Raamana, Wei Xiong Wen, Nicole A. Kochan, Henry Brodaty, Perminder Singh Sachdev, Lei Wang, Mirza Faisal Beg · 2014 · Frontiers in Neurology
  21. Loss of mitochondrial enzyme GPT2 causes early neurodegeneration in locus coeruleus
    Ozan Baytaş, Julie A. Kauer, Eric M. Morrow · 2022 · Neurobiology of Disease
  22. Distribution of SLC10A4, a Synaptic Vesicle Protein in the Human Brain, and the Association of this Protein with Alzheimer's Disease-Related Neuronal Degeneration
    Svetlana N. Popova, Irina I. Alafuzoff · 2013 · Journal of Alzheimer s Disease
  23. Elevated Cerebrospinal Fluid Norepinephrine in the Elderly can Link Depression and A Reduced Glymphatic System as Risk Factors for Alzheimer’s Disease
    Patricia Szot · 2016 · Journal of Aging Science
  24. Epigenetic dysregulation in Alzheimer’s disease: cause or consequence?
    Daniël van den Hove, Günter Kenis, Bart P. F. Rutten · 2014 · Epigenomics
  25. Vascular Risk Factors and Midlife Cognition
    Angela Lee Jefferson · 2014 · Circulation
  26. Aβ, tau, α-synuclein, huntingtin, TDP-43, PrP and AA are members of the innate immune system: a unifying hypothesis on the etiology of AD, PD, HD, ALS, CJD and RSA as innate immunity disorders
    CLAUDIU I. BANDEA · 2013 · bioRxiv (Cold Spring Harbor Laboratory)
  27. Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer’s disease
    Claude M. Wischik, Richard G. Stefanacci, Peter Bentham, Serge G. Gauthier, Henrik Zetterberg, Gordon Keith Wilcock, Lutz Froelich, Alistair S. Burns, Emer MacSweeney, Clive G. Ballard et al. · 2026 · The Journal of Prevention of Alzheimer s Disease
  28. Associations Between Brainstem Volume and Alzheimer’s Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study
    Heidi I.L. Jacobs, Adrienne O’Donnell, Claudia Liliana Satizábal, Cristina Lois, Daniel J. Kojis, Bernard Jimmy Hanseeuw, Emma G. Thibault, Justin S. Sanchez, Rachel F. Buckley, Qiong Yang et al. · 2022 · Journal of Alzheimer s Disease
  29. Tau Acts in Concert With Kinase/Phosphatase Underlying Synaptic Dysfunction
    Xing Fan, Liye Xia, Zheng Zhou, Yanyan Qiu, Chenhao Zhao, Xiaomin Yin, Wei Qian · 2022 · Frontiers in Aging Neuroscience
  30. The Locus Coeruleus – Noradrenaline system: Looking into Alzheimer’s therapeutics with rose coloured glasses
    Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Sukhbir Singh, Hafiz Antar Makeen, Mohammed Albratty, Hassan A. Alhazmi, Saurabh Bhatia, SIMONA GABRIELA BUNGAU · 2022 · Biomedicine & Pharmacotherapy
  31. Exploring potential developmental origins of common neurodegenerative disorders
    James P. Catlin, Christine E. Schaner Tooley · 2024 · Biochemical Society Transactions
  32. Pure argyrophilic grain disease revisited: independent effects on limbic, neocortical, and striato-pallido-nigral degeneration and the development of dementia in a series with a low to moderate Braak stage
    Osamu Yokota, Tomoko Miki, Hanae Nakashima‐Yasuda, Hideki Ishizu, Takashi Haraguchi, Chikako Ikeda, Masato Hasegawa, Akinori Miyashita, Takeshi Ikeuchi, Naoto Nishikawa et al. · 2024 · Acta Neuropathologica Communications
  33. Biomarkers for Alzheimer's: the sequel of an original model
    Giovanni Battista Frisoni, Kaj Blennow · 2013 · The Lancet Neurology
  34. Structural imaging in early pre-states of dementia
    Charles D. Smith · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  35. Pattern of tau hyperphosphorylation and neurotransmitter markers in the brainstem of senescent tau filament forming transgenic mice
    Kerstin Morcinek, Christoph N. Köhler, Jürgen Götz, Hannsjörg Schröder · 2012 · Brain Research
  36. Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer’s disease
    Ravikumar Ponnusamy, Margaret Windy McNerney, Shahrzad Moghadam, Ahmad Salehi · 2017 · Brain Research
  37. Negative environmental influences on the developing brain mediated by epigenetic modifications
    Maya Komar-Fletcher, Julia Wojas, Maria Rutkowska, Gabriela Raczyńska, A Nowacka, Joanna Michalina Jurek · 2023 · Exploration of neuroscience
  38. Brain aging and Alzheimer’s disease, a perspective from non-human primates
    Isidró Ferrer · 2024 · Aging
  39. Spatial proteomic differences in chronic traumatic encephalopathy, Alzheimer's disease, and primary age‐related tauopathy hippocampi
    Timothy E. Richardson, Miranda E. Orr, Timothy C. Orr, Susan Karijn Rohde, Alexander J. Ehrenberg, Emma L Thorn, Thomas D. Christie, Victoria Flores Almazan, Robina Afzal, Claudia De Sanctis et al. · 2024 · Alzheimer s & Dementia
  40. Current Conceptual View of Alzheimer’s Disease
    Karl Herrup · 2012 · Advances in biological psychiatry
  41. Novel ThickNet features for the discrimination of amnestic MCI subtypes
    Pradeep Reddy Raamana, Wei Xiong Wen, Nicole A. Kochan, Henry Brodaty, Perminder Singh Sachdev, Lei Wang, Mirza Faisal Beg · 2014 · NeuroImage Clinical
  42. Decreased excitability of locus coeruleus neurons during hypercapnia is exaggerated in the streptozotocin-model of Alzheimer's disease
    Mariane Cristine Vicente, Chuma M. Humphrey, Luciane H. Gargaglioni, Tim D. Ostrowski · 2020 · Experimental Neurology
  43. Early brainstem [18F]THK5351 uptake is linked to cortical hyperexcitability in healthy aging
    Maxime Van Egroo, Daphné Chylinski, Justinas Narbutas, Gabriel Besson, Vincenzo Muto, Christina Schmidt, Davide Marzoli, Paolo Cardone, Nora Vandeleene, Martin Grignard et al. · 2020 · JCI Insight
  44. Proteomic Network Analysis of Alzheimer’s Disease Cerebrospinal Fluid Reveals Alterations Associated with APOE ε4 Genotype and Atomoxetine Treatment
    Eric B. Dammer, Anantharaman Shantaraman, Lingyan Ping, Duc Minh Duong, Ekaterina Sergeevna Gerasimov, Suda Parimala Ravindran, Valborg Guðmundsdóttir, Elisabet Alexandra Frick, Gabriela Gómez, Keenan A. Walker et al. · 2023 · medRxiv
  45. Locus coeruleus tau is linked to successive cortical tau accumulation
    Dahyun Yi, Min Soo Byun, Joon Hyung Jung, Gijung Jung, Hye‐Jin Ahn, Yoon Young Chang, Musung Keum, Jun‐Young Lee, Yun‐Sang Lee, Yoon‐Keun Kim et al. · 2024 · Alzheimer s & Dementia
  46. Early signs of neuron autonomous and non‐autonomous hyperexcitability in locus coeruleus noradrenergic neurons of a mouse model of tauopathy and Alzheimer's disease
    Zhong‐Min Wang, Valentina P. Grinevich, William R. Meeker, Jie Zhang, María Laura Messi, Evgeny A. Budygin, Osvaldo Delbono · 2025 · Acta Physiologica
  47. Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease
    Ronnie D. Shade, Jennifer A. Ross, Elisabeth J. Van Bockstaele · 2022 · Frontiers in Aging Neuroscience
  48. Recent Advances in the Treatment and Management of Alzheimer’s Disease: A Precision Medicine Perspective
    Deepali Shukla, Anjali Suryavanshi, Sanjay Kumar Bharti, Vivek Asati, Debarshi Kar Mahapatra · 2024 · Current Topics in Medicinal Chemistry
  49. The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer’s Disease: Shortcomings in Prodromal Diagnosis
    Levente Szalárdy, Dénes Zádori, Péter Klivènyi, László Vécsei · 2016 · Journal of Alzheimer s Disease
  50. Characterization of microtubule-associated protein tau isoforms and Alzheimer’s disease-like pathology in normal sheep (Ovis aries): relevance to their potential as a model of Alzheimer’s disease
    Emma S. Davies, Russell M. Morphew, David J. Cutress, A. Jennifer Morton, Sebastian D. McBride · 2022 · Cellular and Molecular Life Sciences
  51. Retinotopic degeneration of the retina and optic tracts in autosomal dominant Alzheimer's disease
    Suman Adhikari, Yuchuan Qiao, Maxwell Singer, Abhay P. Sagare, Xuejuan Jiang, Yonggang Shi, John Matthew Ringman, Amir H. Kashani · 2023 · Alzheimer s & Dementia
  52. Locus coeruleus pathology is associated with cerebral microangiopathy at autopsy
    Whitney M. Freeze, Susanne J. van Veluw, Willemijn J. Jansen, David Alan Bennett, Heidi I.L. Jacobs · 2023 · Alzheimer s & Dementia
  53. Chronic traumatic encephalopathy neuropathologic change is uncommon in men who played amateur American football
    Grant L. Iverson, Pouya Jamshidi, Amanda Fisher‐Hubbard, Amy Deep‐Soboslay, Thomas M. Hyde, Joel E. Kleinman, Joyce L. deJong, Claire E. Shepherd, Lili‐Naz Hazrati, Rudolph J. Castellani · 2023 · Frontiers in Neurology
  54. Activation of β2-adrenergic receptors prevents AD-type synaptotoxicity via epigenetic mechanisms
    Ming Jin, Zhiyun Wei, Nagendran Ramalingam, Meng Xiao, Anqi Xu, Xiaohan Yu, Qingyang Song, Wen Liu, Jianhua Zhao, Dainan Zhang et al. · 2023 · Molecular Psychiatry
  55. The Adult Neurogenesis Theory of Alzheimer’s Disease
    Carlo Abbate · 2023 · Journal of Alzheimer s Disease
  56. Alzheimer’s Disease Neuropathological Change in Aged Non-Primate Mammals
    Isidró Ferrer · 2024 · International Journal of Molecular Sciences
  57. Adapting to Dementia in Society: A Challenge for Our Lifetimes and a Charge for Public Health
    Simon D’Alton, Sally Hunter, Peter John Whitehouse, Carol Brayne, Daniel R. George · 2014 · Journal of Alzheimer s Disease
  58. Transcutaneous vagus nerve stimulation (tVNS) as a potential therapeutic application for neurodegenerative disorders – A focus on dysautonomia in Parkinson's disease
    Daniel W.K. Ko · 2021 · Autonomic Neuroscience
  59. Looking at Alzheimer’s Disease Pathogenesis from the Nuclear Side
    Laura D’Andrea, Ramona Stringhi, Mónica Di Luca, Elena E. Marcello · 2021 · Biomolecules
  60. Are we ready to use anti-amyloid therapy in Alzheimer's disease?
    Sônia Maria Dozzi Brucki, Karolina Gouveia César‐Freitas, Raphael Ribeiro Spera, Conrado Regis Borges, Jerusa Smid · 2022 · Arquivos de Neuro-Psiquiatria
  61. An Alzheimer’s Disease Mechanism Based on Early Pathology, Anatomy, Vascular-Induced Flow, and Migration of Maximum Flow Stress Energy Location with Increasing Vascular Disease
    Conrad N. Trumbore, Aditya Raghunandan · 2022 · Journal of Alzheimer s Disease
  62. Comparison of AT8 immunoreactivity in the locus ceruleus and hippocampus of 154 brains from routine autopsies
    Koichi Okamoto, Masakuni Amari, Toshio Fukuda, Keiji Suzuki, Masamitsu Takatama · 2017 · Neuropathology
  63. Neurobiological Mechanisms Involved in the Pathogenesis of Alzheimer’s Disease
    Fayaz Ahmad Mir, Zaigham Abbas Rizvi · 2019 · Springer eBooks
  64. Calbindin-D28K, parvalbumin, and calretinin in young and aged human locus coeruleus
    Sydney R. Lamerand, Ryan K. Shahidehpour, Iván Alejandro De León Ayala, Tamar D. Gefen, Marsel M. Mesulam, Eileen H. Bigio, Changiz Geula · 2020 · Neurobiology of Aging
  65. Can tauopathy shake the amyloid cascade hypothesis?
    Venugopalan Y. Vishnu · 2013 · Nature Reviews Neurology
  66. Behavioral and Neurophysiological Implications of Pathological Human Tau Expression in Serotonin Neurons
    Nazmus S. Khan, Juan Uribe Isaza, Nahid Rouhi, Naila F. Jamani, Shaista Jabeen, Amisha K. Gill, Mio Tsutsui, Frank Visser, Derya Sargin · 2024 · ACS Chemical Neuroscience
  67. From inflammatory signaling to neuronal damage: Exploring NLR inflammasomes in ageing neurological disorders
    Jingwen Zhang, Dong Xie, Danli Jiao, Shuang Ying Zhou, Shimin Liu, Ziyong Ju, Li Hu, Qi Li, Chongjie Yao, Zhao Chen · 2024 · Heliyon
  68. Importance of Gut Microbiota Dysbiosis and Circadian Disruption–Associated Biomarkers in Emergence of Alzheimer’s Disease
    Simranjit Kaur, Deepali Kumari, Manoj P. Dandekar · 2025 · Molecular Neurobiology
  69. Noradrenaline Regulation of Brain-Body Communication
    Giselle Fernandes, Ruby M. Lam, Ji Ho Park, Gabrielle T Drummond, Mriganka Sur · 2025 · Advances in experimental medicine and biology
  70. Anterograde and Retrograde Propagation of Inoculated Human Tau Fibrils and Tau Oligomers in a Non-Transgenic Rat Tauopathy Model
    Lea Langer Horvat, Ena Španić, Mirjana Babić Leko, Klara Zubčić, Luka Horvat, Maja Mustapić, Patrick R. Hof, Goran Šimić · 2023 · Biomedicines
  71. Regenerating Locus Coeruleus‐Norepinephrine ( LC ‐ NE ) Function: A Novel Approach for Neurodegenerative Diseases
    Ya-Na Yang, Yunlong Tao · 2025 · Cell Proliferation
  72. EuroTau: towing scientists to tau without tautology
    Amritpal K. Mudher, Jean‐Pierre Brion, Jesús Ávila, Miguel Medina, Luc Buée · 2017 · Acta Neuropathologica Communications
  73. Early β adrenoceptor dependent time window for fear memory persistence in APPswe/PS1dE9 mice
    Smitha Karunakaran · 2021 · Scientific Reports
  74. An insight into Alzheimer’s disease and its on-setting novel genes
    Jaanaky Vigneswaran, Sivaloganathan Anogh Muthukumar, Mohamed Shafras, Geetika Pant · 2021 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
  75. Identification of gene networks mediating regional resistance to tauopathy in late-onset Alzheimer’s disease
    Christopher A. Ayoub, Connor S. Wagner, Jeff Kuret · 2023 · PLoS Genetics
  76. Atrophy links lower novelty‐related locus coeruleus connectivity to cognitive decline in preclinical AD
    Christoph Schneider, Prokopis C. Prokopiou, Kathryn V. Papp, Nina Engels, Stephanie Hsieh, Truley Juneau, Aaron P. Schultz, Dorene M. Rentz, Reisa Anne Sperling, Keith A. Johnson et al. · 2024 · Alzheimer s & Dementia
  77. Postmortem imaging and neuropathologic correlations
    Jean C. Augustinack, Andre J. W. van der Kouwe · 2016 · Handbook of clinical neurology
  78. In vivo Characterization of Biochemical Variants of Amyloid-β in Subjects with Idiopathic Normal Pressure Hydrocephalus and Alzheimer’s Disease Neuropathological Change
    Sylwia Libard, Jochen Walter, Irina I. Alafuzoff · 2021 · Journal of Alzheimer s Disease
  79. Enhanced expression of autophagy‐related p62 without increased deposits of neurodegeneration‐associated proteins in glioblastoma and surrounding tissue – An autopsy‐based study
    Sigrid Klotz, Gerda Ricken, Matthias Preusser, Karin Ute Dieckmann, Georg Widhalm, Karl Rössler, Peter A. Fischer, Ognian Kalev, Adelheid Wöehrer, Gábor Géza Kovács et al. · 2022 · Brain Pathology
  80. New Insight in The Molecular Mechanisms of Neurodegenerative Disease
    Anna Meiliana, Nurrani Mustika Dewi, Andi Wijaya · 2018 · The Indonesian Biomedical Journal
  81. Ultra-Early Screening of Cognitive Decline Due to Alzheimer’s Pathology
    Pengxu Wei · 2023 · Biomedicines
  82. The effects of locus coeruleus ablation on mouse brain volume and microstructure evaluated by high-field MRI
    Rasmus West Knopper, Christian Stald Skoven, Simon Fristed Eskildsen, Leif Østergaard, Brian Hansen · 2024 · Frontiers in Cellular Neuroscience
  83. Neuropathological examination of 12 cases of familial Parkinson’s disease with LRRK2 I2020T mutation including tau and TDP-43 pathology
    Akiko Uchino, Kazuko Hasegawa, Saburo Yagishita, Makiko Nagai, Mieko Ogino, Yutaka Ogino, Hiroyuki Hatsuta, Shigeo Murayama, Yuko Saito · 2025 · Journal of Neurology
  84. The engagement of microglia in tau-targeted immunotherapy in Alzheimer’s disease
    Denisa Palova, Natalia Turic Csokova, Karina Markova, Eva Kontseková, Branislav Kováčech, Monika Žilková · 2021 · General Physiology and Biophysics
  85. Noradrenergic Modulation of the Piriform Cortex: A Possible Avenue for Understanding Pre-Clinical Alzheimer’s Disease Pathogenesis
    Vishaal Rajani, Qi Yuan · 2022 · Frontiers in Cellular Neuroscience
  86. The role of neuroinflammation in developmental neurotoxicity, tackling complexity in children's exposures and outcomes
    Amedeo D’Angiulli · 2018 · Advances in neurotoxicology
  87. Association of Subjective Hearing Loss and Apolipoprotein E ε4 Allele on Alzheimer's Disease Neurodegeneration
    Ryan M. Neff, Gregory A. Jicha, Gregory S. Hawk, Matthew L. Bush, Beth N. McNulty · 2020 · Otology & Neurotology
  88. Alzheimer's Disease, Neural Basis of
    Heiko Braak, Kelly Del Tredici-Braak · 2015 · Elsevier eBooks
  89. Contributions of connectional pathways to shaping Alzheimer’s disease pathologies
    Salma Bougacha, Daniel Roquet, Brigitte Landeau, Elise Saul, Mikaël Naveau, Siya Sherif, Alexandre Bejanin, Marc Dhénain, Ashish Raj, Denis Vivien et al. · 2024 · Brain Communications
  90. Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States
    Madison K. Kuhn, Elizabeth A. Proctor · 2024 · Proteins Structure Function and Bioinformatics
  91. The neuropathologic basis for translational biomarker development in the macaque model of late-onset Alzheimer's disease
    Caroline J. Zeiss, Anita J Huttner, Angus Clark Nairn, Amy F.T. Arnsten, Dibyadeep Datta, Stephen M. Strittmatter, Brent Vander Wyk, Alvaro Duque · 2025 · Journal of Alzheimer s Disease
  92. Progressive supranuclear palsy: Neuropathology of patients with a short disease duration due to unexpected death
    Lu Zhang, Yasuko Toyoshima, Akari Takeshima, Hiroshi Shimizu, Itsuro Tomita, Osamu Onodera, Hitoshi Takahashi, Akiyoshi Kakita · 2020 · Neuropathology
  93. Revisit the Cellular Transmission and Emerging Techniques in Understanding the Mechanisms of Proteinopathies
    Jinwen Jiang, Yu Liu, Qihui Wu · 2021 · Frontiers in Neuroscience
  94. Increased Radiation Sensitivity in Patients with Phelan-McDermid Syndrome
    Sarah Jesse, Lukas Kuhlmann, Laura S. Hildebrand, Henriette Magelssen, Martina Schmaus, Beate Timmermann, Stephanie Andres, Rainer Fietkau, Luitpold Valentin Distel · 2023 · Cells
  95. Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging
    Isidró Ferrer · 2024 · Journal of Alzheimer s Disease
  96. Locus Coeruleus Degeneration in Essential Tremor With Mild Cognitive Impairment: A Neuromelanin MRI Study
    Yuelin Fang, Cheng Zhou, Bingting Zhu, Jiasi Liu, Sicheng Liu, Xiaojun Guan, Tao Guo, Xiaojun Xu, Minming Zhang, Jun Tian et al. · 2025 · CNS Neuroscience & Therapeutics
  97. Alzheimer's Disease-Related Lesions
    Irina I. Alafuzoff · 2012 · Journal of Alzheimer s Disease
  98. Introduction
    Heiko Braak, Kelly Del Tredici · 2014 · Advances in anatomy, embryology and cell biology
  99. Az Alzheimer-kór heterogenitása
    Nóra Balázs, Tibor Kovács · 2021 · Orvosi Hetilap
  100. Amyloid and anatomical correlates of executive functioning in middle-aged offspring of patients with late-onset Alzheimer's disease.
    Bárbara Duarte-Abritta, Stella M. Sánchez, Carolina Abulafia, Deborah Gustafson, Silvia Vázquez, Gustavo Emilio Sevlever, Mariana Nair Castro, Leticia Fiorentini, Mirta Fabiana Villarreal, Salvador Martin Guinjoan · 2021 · Psychiatry Research Neuroimaging